Where Innovation & Clinical Precision
Meet Human Purpose in Nutritional Medicine
ALP Life Sciences was founded as a lipid membrane and metabolism research project. Two brothers with decades of healthcare experience were inspired to create ALP when they encountered interesting new developments in lipid membrane science. Robert A. Barker, MD, a family physician with more than 30 years of experience, and David Barker, founder and CEO of a life sciences research and services company, formed ALP to explore these opportunities. A major university and PhD with lipid expertise conducted research on the core ALP scientific hypothesis and validated it. The first ALP patent was granted. The ALP project seeks to build a bridge between traditional medicine and nutritional medicine based on the new and emerging lipid science.
One of the important products in the ALP development pipeline is a potential botanical treatment to restore more optimal liver metabolism and reduce fat levels in the liver. The unique lipid therapy approach, known as "LipoVeson", aka the LipoVeson platform, has other important and far reaching applications for human health. The ongoing LipoVeson research includes the importance of omega 3 levels in red blood cells (RBC) and the key phospholipids (PL) in RBC and other membranes in liver cells and all other cells. It is increasingly recognized in the peer reviewed research that omega 3 lipids play important roles in lipid membranes and maintaining human health. The amount of and the correct form of lipids is key.
Omega 3s provide a standalone intervention for prevention and improved health outcomes. The new lipid therapeutic approach in development at ALP requires preparation with optimally formulated omega-3 supplements in both triglyceride (TAG) and phospholipid (PL) form. The importance of the choline containing phospholipids in human health is underappreciated. The important objective is to raise the Omega-3 Index (O3i) into the optimal 8-12% range. The peer reviewed research is now piling up that demonstrates the importance of an O3i in the 8-12% range for inflammatory disease prevention and maintaining optimal human health. Through research, the ALP team recognized the significant need for high-quality, optimally formulated omega-3 supplements that enable proactive, health-conscious consumers to achieve an Omega-3 Index (O3i) in the optimal 8-12% range and help reduce the risks of inflammatory diseases.
The ALP Omega-3 Protocol was developed to provide a simple method using the correct forms of TAG and PL omega 3s to target, raise and optimize omega 3 levels, including the levels in lipid membranes. Insuring optimal omega 3 levels is phase one of the research. Triglyceride (TAG) fish oil does the heavy lifting of the omega 3 index (O3i) while the krill oil phospholipids (PL) provide important additional membrane boost and function. Both Robert and David now target the high end of the recommended O3i range with the ALP Omega-3 Protocol. Give it a try and note the changes in your blood panels.
We don't guess. We test, we dose, we test again. Anything less is wishful thinking.— Robert A. Barker, MD
What does ALP stand for? It is shorthand for Applied Lipid Polymorphism. Fancy words, but the simple idea behind ALP is that with doses of lipids you can remodel the lipids and membranes in the ~30 trillion cells in your body, reducing your risks of inflammatory diseases. In short, ALP stands for "lipids remodeling lipids". Taking high quality lipids to remodel low quality lipids, including your lipid membranes with important health benefits. ALP’s lipid research led to a recognition of the important role of the Omega-3 Index (O3i) to track your inflammatory risks and your lipid remodeling progress. The O3i is typically too low, below 5%, when inflammatory diseases are present.
ALP’s fatty liver disease research continues. In the meantime, ALP recommends that everyone that takes omega 3 supplements in any form know and track their O3i. Without testing, you have no way of knowing if your O3i is too low and in the “at risk” range. The mounting research and science indicates an important question for those seeking to optimize their health. How high is your Omega-3 Index?
ALP High-3 vs Other Brands
Our research-backed formula and unparalleled production quality differentiates ALP High-3 from other omega-3 fish oil supplements. Every pill delivers pure, potent fish oil for real health benefits. The high absorption rate and levels of DHA and EPA in ALP High-3 make it a better value than other available omega-3 supplements. For the exact math, check out our omega-3 calculator.
Our customers note that the double enteric coating of every ALP High-3 eliminates unwanted fish burps and gastrointestinal stress. There is finally a fish oil supplement you will enjoy taking- as much as you enjoy the health benefits.
Single Serving EPA/DHA Analysis
| ALP High-3 |
Typical Prescription |
Basic Over The Counter |
|
|---|---|---|---|
| EPA | 800mg | 679mg | 180mg |
| DHA | 600mg | 246mg | 120mg |
| Form | Triglyceride | Ethyl Ester | Ethyl Ester |
| Coating | Enteric Option* | N/A | N/A |
Frequently Asked Questions
Clear answers to your questions about the science, absorption mechanics, and clinical standards behind the ALP Protocol.
The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes. ALP targets an O3i of 8-12% because levels below 5% correlate with higher inflammatory disease risk.
Normally a negative effect – high glucose (sugar) levels from starches and carbohydrates cause the body to increase its natural production of insulin, which in turn converts DGLA, an omega 6 fatty acid, to arachidonic acid (AA), which is the main culprit in prolonging the pro-inflammatory cause of accelerated chronic disease.
Actually, yes – statins are important in lowering cholesterol, and you should take them as your doctor recommends, but statins have been shown to increase arachidonic acid production, a known causative factor in chronic disease.
Medical science is learning more every day about this process of inflammation, and perhaps we can simplify it. We now know that there are two types of inflammation, known as pro-inflammatory response, and anti-inflammatory response. When damage occurs in the body, our first immune response is pro-inflammatory – its function is cell destruction. It simply clears away damaged cells so that the body can rebuild. This response is then followed by the anti-inflammatory response – its function is one of cell rejuvenation. It rebuilds and replaces damaged cells, and might be best understood as “the healing process.” What we understand as wellness can be described as a proper balance between these two functions. Problem: an unbalanced diet, one high in “negative” fatty acids, strongly supports the pro-inflammatory response, which becomes harmful when it a) continues the cell destruction phase when no longer needed, and b) continues to negatively impact the cell rejuvenation phase. The result is an increase in chronic inflammatory diseases over time. Such conditions as arthritis, asthma, cancer, type II diabetes, Crohn’s disease, heart disease, and others have been linked to this uncontrolled, ongoing pro-inflammatory response.
Wouldn’t we like to know that about everything we take? Fortunately, there is a simple way to do that. The Omega Score whole blood test, which includes the AA/EPA ratio test, is the appropriate measure of the ratio of pro–versus anti-inflammatory processes underway in the body, based on diet and omega 3 (the “good” omegas) versus omega 6 (the bad omegas) consumption, and these results have been directly linked to life expectancy factors. By using this simple “finger stick” blood test, both physician and patient can literally watch the good anti-inflammatory process taking place. This test focuses not only on the amount of omega 3s and other omegas, but most importantly on the balance between omega 3s (the EPA part) and omega 6s (the AA part) as well. Here are some specific examples:
- Increasing the omega-3 whole blood score from 6.1% to 10.2% has been linked to an 80% lower risk of sudden cardiovascular death;
- An omega 3 serum equivalence equal to or greater than 7.2 has been linked to a 32% reduction in heart disease;
- An EPA/DHA serum equivalence equal to or greater than 4.6 has been linked to a 70% reduced risk of death from fatal ischemic heart disease.
By repeating the simple Omega Score “finger stick” test every two months, therapeutic progress can be validated. Patients can order the Omega Score and AA/EPA ratio test from the ALP webstore. Physicians can refer patients to the ALP webstore to order the Omega Score test, and/or physicians can register through ALP to become an Omega Score test provider and ALP will relay the physicians information to Nutrasource Diagnostics, Inc.
The objective here is to increase the presence of EPA/DHA in the body, and likewise minimize the presence of AA — put this way, the answer becomes easy:
- 98% of all fats absorbed, stored, and transported in the human body are in natural triglyceride form– the supplement you take should say “natural triglyceride form” on the label – accept no substitutes;
- Enteric coating substantially increases the absorption rate of natural triglyceride fish oil preparations;
- ALP High 3 is formulated from the highest quality pharmaceutical grade fish oil — five star rated by the international Fish Oil Standards (IFOS) Organization for purity and content — look for the IFOS logo on the label;
- Because of absorption in the intestines, not the stomach, ALP High 3 achieves a significantly better absorption/penetration of omega 3 fatty acids into phospholipids (determined by red blood cell analysis), thereby boosting EPA/DHA levels, and effectively displacing arachidonic acid (AA) almost completely. Enteric coating has also been shown to reduce occasional burping, fishy aftertaste or G.I. upset.
- New enteric-coated natural triglyceride ALP High 3 provides concentrations/plasma levels/measurable efficacy at the site of inflammation.
Good question, and you are right – ocean contaminants are a consideration. What’s in the water is in the fish. Some fish, especially shark, king mackerel, and farm-raised salmon, can be contaminated with mercury, PCBs, and other industrial and environmental chemicals/pollutants. ALP High 3 fish oils are derived from mackerel, tuna, salmon, sturgeon, mullet, bluefish, anchovies, sardines, herring, trout, and menhaden. ALP High 3 fish oil is carefully purified to reduce heavy metals, dioxins, and PCBs, in addition to being tested for oxidation levels. ALP High 3 exceeds strict international standards for guaranteed pure and potent fish oil, will always exceed the stated amounts of EPA and DHA, and is manufactured in a cGMP facility. Always insist on the IFOS five-star rating — your guarantee of quality and purity when selecting fish oil supplements.
The only contraindication to their use is known hypersensitivity to omega 3 fish oils (such as anaphylaxis), EPA, DHA or any of its components. Care should be exercised during pregnancy or lactation, in patients facing surgery, those with bleeding problems or in patients undergoing any other treatment (either drug therapies or nutritional supplements) which may affect the ability of the blood to clot. Routine liver function tests should be performed, specifically when higher doses are being utilized. There are no known interactions with foods. Using fish oil supplements concomitantly with drugs that lower blood pressure (i.e., captopril, and enalapril, losartan, diltiazem, amlodipine, hydrochlorothiazide, furosemide, and others) may increase the effect of these drugs and may excessively lower blood pressure in some patients. The most commonly reported adverse reactions to fish oil therapy include “burping”, dyspepsia, and taste perversion.
No, but it’s a good question! Our bodies can naturally manufacture the good things that fish oil provides as replacements from the fats we consume – the problem is that today’s diet is high in different kinds of fats — processed, polyunsaturated fatty acids, partially hydrogenated vegetable oil, and other types of fats — these don’t contain enough of the proper “raw materials”, and in some cases produce compounds that actually work against the production of the proper omega-3 fatty acids (the beneficial ones). ALP High 3 provides high concentrations of EPA and DHA, beneficial omega-3 fatty acids, in the natural form which our bodies can easily absorb and use.
The research-recommended Omega-3 Index range is 8–12%. Many people sit below 5%, which is considered the danger zone. If you are young, healthy, and not overweight, the low end (8–9%) can be acceptable. As you age or face inflammatory-related health conditions, ALP’s strategy is to target the high end of the range — 11–12%, which ALP calls the “Summit.”
Plan A uses ALP High-3 TAG (fish oil in triglyceride form) only — and it is a good plan. Plan A+ adds ALP High 3–PL krill oil in phospholipid form — it is the highly recommended plan because krill oil phospholipids carry choline and target efficient remodeling of lipid membranes in the blood, brain, tissue, and organs.
Fish oil (TAG) does the heavy lifting — it delivers higher concentrations of EPA and DHA per serving. Krill oil (PL) adds the “lipid-membrane magic” — its phospholipid form carries choline and targets cell membrane integration more efficiently. Together, they give you two biologically active delivery systems working in concert to raise and maintain your Omega-3 Index.
For the “Summit” target (11–12% O3i), the typical person needs approximately 3,000 mg (3 g) of EPA+DHA per day from all sources. Lower targets (Base Camp at 8–9%, Ascent at 9–11%) use proportionally less. You should always confirm with testing, since your metabolism, diet, genetics, and exercise habits affect your personal O3i.
ALP recommends the Omega-3 Index test by OmegaQuant.com, which uses red blood cells (RBC) and is a simple finger-prick test you can do at home. The O3i RBC test is increasingly used in peer-reviewed omega-3 research, so your results let you follow the emerging science. Other testing options are also available — discuss with your healthcare provider.
ALP krill oil contains omega-3s in a phospholipid form with choline bound to the phospholipid. Up to 90% of Americans fall short of the necessary daily intake of choline, and over 60% carry a genetic mutation that predisposes them to choline deficiency. The ALP Protocol is designed to address both omega-3 and choline deficiency together — emerging research shows these deficiencies often coincide and have compounding inflammatory consequences.